Ganciclovir
- Product NDC
- 76233-072
- 11-digit product format
- 762330072
- Labeler code
- 76233
- Product ID
- 76233-072_1187c030-f17b-46ad-8be6-69f0bea3ff41
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ganciclovir Sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Laboratorio Reig Jofre, S.A.
- Application
- ANDA207815
- Marketing category
- ANDA
- Marketing start
- 2020-08-25
- Marketing end
- 0000-00-00
- Substance
- GANCICLOVIR SODIUM
- Active strength
- 500 mg/10mL
- Pharmacologic classes
- Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Analog Antiviral [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 76233-072-94 | 76233007294 | 25 VIAL in 1 CARTON (76233-072-94) > 10 mL in 1 VIAL (76233-072-10) | 25 vial | 2020-08-25 | 0000-00-00 | No | No | Current |